Browse all articles

Home Get the app

Head to head Published Apr 25, 2026

Apigenin vs German Chamomile Extract for Calming and Sleep

Pick German chamomile extract if you want the option with better human evidence for calming and subjective sleep quality. Pick isolated apigenin only if you specifically want a single-compound, low-ingredient sleep-stack component and accept that direct human sleep evidence is much thinner.

Evidence: promising 9 criteria 10 sources

Evidence summary

Evidence summary

For calming and subjective sleep support, German chamomile extract wins; for a simple single-compound sleep-stack ingredient, apigenin is the cleaner pick, but direct human sleep evidence is much thinner.

  • Across human anxiety and insomnia studies, chamomile improved calming and subjective sleep outcomes more consistently than apigenin.1
  • Apigenin wins for ingredient minimalism, and formulation research has focused on improving its oral delivery.6
  • Chamomile carries ragweed-family allergy risk and interaction cautions with warfarin, sedatives, and other prescription drugs.7

The verdict

German chamomile extract is the stronger default for most calming and sleep-support buyers because the human evidence is tied to the extract, not to isolated apigenin alone. Isolated apigenin wins for label simplicity and targeted experimentation, but chamomile wins the practical evidence test, especially when the product is standardized to apigenin markers and the buyer is not at high allergy or interaction risk.12710

The contenders

Two ways to approach the same goal

Option A

Apigenin (isolated flavone)

Standardization

Usually sold as isolated apigenin, often labeled as a high-purity flavone such as 95 percent to 98 percent apigenin. There is no widely accepted clinical standard for isolated apigenin for sleep, and human calming trials mostly used chamomile extract standardized to apigenin content rather than isolated apigenin alone.

Forms

Capsules, tablets, powders, liposomal liquids, and blended sleep formulas.

Typical dosage

Common supplement labels often use about 25 to 100 mg before bed, but this is not a clinically established sleep dosage. Human pharmacokinetic evidence for purified oral apigenin is limited, and a human food study used parsley providing about 18 mg apigenin equivalents, not an isolated sleep supplement.

Strengths

  • Cleaner single-ingredient choice for buyers who want to avoid a full botanical extract with many plant compounds.
  • Easier to compare labels by milligrams of apigenin because the active listed on the front of the bottle is the compound itself, not a plant ratio.
  • May fit buyers who are experimenting with low-dose, non-melatonin sleep stacks, but direct human sleep evidence for isolated apigenin remains limited.

Trade-offs

  • We found no strong head-to-head trial comparing isolated apigenin with German chamomile extract for sleep or calm, and no robust randomized human trial proving isolated apigenin improves sleep quality.
  • Oral absorption is a practical weak point. A review notes that comprehensive human pharmacokinetic studies of purified oral apigenin have not yet been conducted, and formulation studies are still mostly preclinical.
  • Single-compound products can look more precise than chamomile, but the milligram number is not the same as proven human effect for sleep.

Safety

Apigenin is a food-derived flavone, but concentrated isolated use has less human safety testing than chamomile extract. Because apigenin may affect drug-handling proteins and enzymes in laboratory research, people taking sedatives, anticoagulants, antiplatelet drugs, hormone-related medicines, or multiple prescriptions should ask a clinician before use.57

Option B

German Chamomile Extract (Matricaria recutita)

Standardization

Clinical studies commonly used pharmaceutical-grade Matricaria recutita or Matricaria chamomilla extract standardized to 1.2 percent apigenin, and quality monographs for chamomile can specify markers such as not less than 0.3 percent apigenin-7-glucoside, not less than 0.15 percent bisabolol derivatives, and not less than 0.4 percent blue volatile oil.

Forms

Capsules, tablets, liquid extracts, teas, powders, and aromatherapy products. This comparison prioritizes oral extract capsules because they are closest to the anxiety and sleep-adjacent clinical studies.

Typical dosage

In the main generalized anxiety disorder trial, participants used 220 mg capsules of chamomile extract standardized to 1.2 percent apigenin. In a longer study, responders received pharmaceutical-grade chamomile extract 1,500 mg per day as 500 mg three times daily during open-label treatment, then responders entered a randomized continuation phase.

Strengths

  • Better human evidence for calm-related outcomes than isolated apigenin, including randomized placebo-controlled research in adults with generalized anxiety symptoms.
  • A systematic review and meta-analysis of 12 randomized or quasi-randomized trials reported that chamomile improved sleep quality, although effects for insomnia and anxiety outcomes were mixed across studies.
  • More complete plant profile than isolated apigenin, including apigenin-related compounds, bisabolol derivatives, and volatile oils that can be assayed for quality control.

Trade-offs

  • Chamomile products vary widely. Tea, low-marker extracts, 10:1 powders, and 1.2 percent apigenin capsules are not interchangeable unless the label gives meaningful marker testing.
  • The best evidence is for anxiety symptoms and subjective sleep quality, not a guaranteed sedative effect on sleep onset the first night.
  • Allergy risk matters for people sensitive to ragweed, daisies, chrysanthemums, marigolds, or related plants.

Safety

Chamomile is usually well tolerated short term, but side effects can include nausea, dizziness, allergic reactions, and rare severe allergic reactions. NCCIH notes possible interactions with warfarin, liver-metabolized drugs, and sedatives, and says pregnancy and breastfeeding safety is not well known.7

Head-to-head

How they compare, criterion by criterion

Human evidence for calming

Winner: B · German Chamomile Extract (Matricaria recutita)

Importance: high

German chamomile extract wins because randomized placebo-controlled research used Matricaria recutita extract in adults with generalized anxiety disorder symptoms, while isolated apigenin has not been tested as well for this buyer goal. The 2009 trial used 220 mg capsules standardized to 1.2 percent apigenin, which means the evidence belongs to a chamomile extract product, not to a standalone apigenin capsule.210

Human evidence for sleep quality

Winner: B · German Chamomile Extract (Matricaria recutita)

Importance: high

Chamomile wins, but not by a landslide. A 2019 systematic review and meta-analysis of 12 randomized or quasi-randomized trials found a significant improvement in sleep quality, while evidence for insomnia itself was less consistent. For isolated apigenin, direct randomized sleep trials in humans remain hard to find.13

Onset and time to effect

Winner: Tie · Either option

Importance: medium

Neither option has strong evidence for a predictable same-night knockout effect. Chamomile studies often assessed outcomes over weeks, including 8 to 12 week anxiety protocols, so it is better framed as gradual calming support than an immediate sedative. Isolated apigenin has even less human timing data.1910

Standardization and label reliability

Winner: Tie · Either option

Importance: high

This depends on product quality. Isolated apigenin is simple when purity is verified, but the dose is not clinically anchored for sleep. Chamomile extract can be excellent when standardized, for example to 1.2 percent apigenin in trials or to pharmacopeial markers such as apigenin-7-glucoside, bisabolol derivatives, and blue volatile oil, but many retail products do not give that level of detail.28

Bioavailability and formulation logic

Winner: B · German Chamomile Extract (Matricaria recutita)

Importance: medium

Chamomile narrowly wins because the human clinical evidence already used oral extract, so buyers do not have to guess whether purified apigenin exposure is enough. For isolated apigenin, a pharmacology review states that comprehensive human studies of purified oral apigenin have not yet been conducted, and a nanoemulsion study showing higher exposure was preclinical rather than a finished sleep trial.56

Tolerability

Winner: A · Apigenin (isolated flavone)

Importance: medium

Isolated apigenin narrowly wins for people who tolerate flavones but want to avoid the wider botanical allergen profile of chamomile. Chamomile was generally well tolerated in trials, but NCCIH highlights allergic reactions, including rare severe reactions, especially in people allergic to related plants such as ragweed and daisies.710

Drug interaction clarity

Winner: A · Apigenin (isolated flavone)

Importance: high

Apigenin wins slightly because it avoids the full herb profile, but this is not a free pass. Chamomile has clearer real-world cautions, including reported interactions with warfarin and possible issues with sedatives and liver-metabolized drugs. Concentrated apigenin still deserves caution because lab and review literature discuss drug-handling pathways, but clinical interaction data are thinner.57

Cost and value per evidence-backed dose

Winner: B · German Chamomile Extract (Matricaria recutita)

Importance: medium

Chamomile extract usually gives better evidence value because the studied product category is the extract itself. Isolated apigenin may look efficient by milligrams, but without a proven sleep dose, a cheaper milligram does not automatically mean better value. The most meaningful value comparison is cost per standardized, trial-like chamomile dose versus cost per experimental apigenin dose.129

Real-world availability

Winner: Tie · Either option

Importance: low

Both are easy to find online. Chamomile is available as tea, extract, and capsules, while apigenin is common in sleep stacks and single-ingredient capsules. The tie reflects availability, not equal evidence quality.78

Which should you choose

By goal and use case

You want the most evidence-backed calming option

Choose B · German Chamomile Extract (Matricaria recutita)

Choose German chamomile extract, preferably one standardized to apigenin content. The best human calming evidence used chamomile extract in adults with generalized anxiety symptoms, not isolated apigenin alone.210

You want a simple, single-compound sleep stack

Choose A · Apigenin (isolated flavone)

Choose isolated apigenin if your priority is ingredient simplicity and you are comfortable treating it as an experiment. This makes the most sense for buyers already tracking sleep timing, next-day grogginess, and dose response, because the direct human sleep evidence is limited.35

You have ragweed, daisy, chrysanthemum, or marigold allergy

Choose A · Apigenin (isolated flavone)

Avoiding chamomile may be the safer default because chamomile can trigger allergic reactions in people sensitive to related plants. Isolated apigenin may reduce exposure to the whole flower allergen profile, although anyone with severe allergies should be cautious with all supplements.7

You take warfarin, sedatives, or several prescription medicines

Choose Tie · Either option

Do not self-select either without a clinician. Chamomile has specific cautions for warfarin, sedatives, and liver-metabolized drugs, while concentrated apigenin has less direct clinical interaction research and should not be assumed interaction-free.57

You want a product closest to clinical anxiety research

Choose B · German Chamomile Extract (Matricaria recutita)

Choose a pharmaceutical-style German chamomile extract standardized around 1.2 percent apigenin if available. That mirrors the extract profile used in the placebo-controlled anxiety trial more closely than a generic chamomile tea or purified apigenin capsule.210

You want occasional evening tea for a wind-down ritual

Choose B · German Chamomile Extract (Matricaria recutita)

Choose chamomile tea for the ritual and sensory cue, but do not equate it with the capsule trials unless the product discloses extract strength and active markers. Tea may still support a calming routine, but its apigenin dose is usually less predictable than standardized extract.18

Safety considerations

Avoid stacking either option with alcohol, sedatives, or multiple sleep supplements until you know your response. German chamomile has the clearer safety record in human calming studies, but it also has clearer cautions: possible allergy, rare severe allergic reactions, possible interaction with warfarin, theoretical additive effects with sedatives, and unknown safety during pregnancy or breastfeeding.710 Isolated apigenin has fewer whole-herb allergy concerns, but concentrated use is less studied in humans. If you use anticoagulants, antiplatelet drugs, hormone-related medicines, seizure medicines, sedatives, or several prescriptions, treat both options as clinician-check supplements rather than casual add-ons.57

Frequently asked

Common questions

Is apigenin just a stronger version of chamomile?

No. Apigenin is one flavone found in chamomile, but chamomile extract contains many compounds and has the stronger human trial record for calming. A high-milligram apigenin capsule is not automatically equivalent to a studied chamomile extract.

Should I choose chamomile tea or chamomile extract capsules?

Choose tea for a low-intensity evening ritual. Choose standardized extract capsules if you want something closer to the clinical research, especially products that disclose apigenin or apigenin-7-glucoside markers.

Can I take apigenin and chamomile together?

It is usually unnecessary because chamomile already contains apigenin-related compounds. Combining them may increase the chance of drowsiness or interactions, especially if you also use alcohol, sedatives, or other sleep aids.

Which is less likely to cause next-day grogginess?

Neither has strong comparative data on next-day grogginess. Start low, avoid stacking, and judge by your own next-morning alertness because both are usually positioned as gentler options rather than strong sedatives.

What label details matter most for German chamomile extract?

Look for the Latin name Matricaria recutita or Matricaria chamomilla, flower extract, extract ratio if provided, and active marker testing such as apigenin, apigenin-7-glucoside, bisabolol derivatives, or volatile oil content.

Related

Read each variant on its own

Standalone evidence guides and systematic reviews for the supplements being compared here.

Sources

  1. 1. Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials (2019) systematic review and meta-analysis ↑
  2. 2. Chamomile (Matricaria recutita) May Have Antidepressant Activity in Anxious Depressed Humans: An Exploratory Study (2012) secondary analysis of randomized placebo-controlled trial ↑
  3. 3. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder (2009) randomized placebo-controlled trial ↑
  4. 4. Bioavailability of apigenin from apiin-rich parsley in humans (2006) human pharmacokinetic food study ↑
  5. 5. Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers? (2021) pharmacology review ↑
  6. 6. Enhancing Oral Bioavailability of Apigenin Using a Bioactive Self-Nanoemulsifying Drug Delivery System: In Vitro, In Vivo and Stability Evaluations (2020) preclinical formulation study ↑
  7. 7. Herb-Drug Interactions: What the Science Says, Chamomile (2026) government safety guidance ↑
  8. 8. Chamomile, United States Pharmacopeia monograph (2026) quality monograph ↑
  9. 9. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial (2016) randomized continuation clinical trial ↑
  10. 10. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder (2016) open-label clinical study ↑

Want personalized recommendations?

Show me what works for me